| Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation S Prockop, E Doubrovina, S Suser, G Heller, J Barker, P Dahi, MA Perales, ... The Journal of clinical investigation 130 (2), 733-747, 2020 | 187 | 2020 |
| Virus-specific T-cell banks for'off the shelf'adoptive therapy of refractory infections RJ O'Reilly, S Prockop, AN Hasan, G Koehne, E Doubrovina Bone marrow transplantation 51 (9), 1163-1172, 2016 | 169 | 2016 |
| Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential Q Zhao, M Ahmed, DV Tassev, A Hasan, TY Kuo, HF Guo, RJ O'Reilly, ... Leukemia 29 (11), 2238-2247, 2015 | 97 | 2015 |
| Immunotherapy with donor T cells sensitized with overlapping pentadecapeptides for treatment of persistent cytomegalovirus infection or viremia G Koehne, A Hasan, E Doubrovina, S Prockop, E Tyler, G Wasilewski, ... Biology of Blood and Marrow Transplantation 21 (9), 1663-1678, 2015 | 87 | 2015 |
| Repeated courses of rituximab in chronic ITP: three different regimens A Hasan, M Michel, V Patel, R Stasi, S Cunningham‐Rundles, ... American journal of hematology 84 (10), 661-665, 2009 | 83 | 2009 |
| Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1+ leukemias E Doubrovina, T Carpenter, D Pankov, A Selvakumar, A Hasan, ... Blood, The Journal of the American Society of Hematology 120 (8), 1633-1646, 2012 | 71 | 2012 |
| Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants RJ O’Reilly, E Doubrovina, D Trivedi, A Hasan, W Kollen, G Koehne Immunologic research 38, 237-250, 2007 | 60 | 2007 |
| Use of humanized severe combined immunodeficient mice for human vaccine development GC Koo, A Hasan, RJ O’Reilly Expert review of vaccines 8 (1), 113-120, 2009 | 50 | 2009 |
| TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies M Ahmed, A Lopez-Albaitero, D Pankov, BH Santich, H Liu, S Yan, ... JCI insight 3 (4), 2018 | 38 | 2018 |
| A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy AN Hasan, WJ Kollen, D Trivedi, A Selvakumar, B Dupont, M Sadelain, ... The Journal of Immunology 183 (4), 2837-2850, 2009 | 38 | 2009 |
| Artificial antigen presenting cells: an off the shelf approach for generation of desirable T-cell populations for broad application of adoptive immunotherapy AN Hasan, A Selvakumar, RJ O’reilly Advancements in genetic engineering 4 (3), 2015 | 33 | 2015 |
| Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8+ T cells for adoptive … AN Hasan, A Selvakumar, E Shabrova, XR Liu, F Afridi, G Heller, I Riviere, ... Clinical & Experimental Immunology 186 (2), 249-265, 2016 | 31 | 2016 |
| T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells RJ O'Reilly, G Koehne, AN Hasan, E Doubrovina, S Prockop Bone marrow transplantation 50 (2), S43-S50, 2015 | 25 | 2015 |
| Intravitreal ocriplasmin in clinical practice: predictors of success, visual outcomes, and complications HL Feng, DB Roth, A Hasan, HF Fine, HM Wheatley, JL Prenner, SP Shah, ... Retina 38 (1), 128-136, 2018 | 24 | 2018 |
| Therapeutic advantages provided by banked virus-specific T-cells of defined HLA-restriction RJ O’Reilly, S Prockop, A Hasan, E Doubrovina Bone marrow transplantation 54 (Suppl 2), 759-764, 2019 | 21 | 2019 |
| 298 Final analysis of the phase 1 trial of NY-ESO-1–specific T-cell receptor (TCR) T-cell therapy (letetresgene autoleucel; GSK3377794) in patients with advanced synovial … S D’Angelo, G Demetri, B Van Tine, M Druta, J Glod, W Chow, N Pandya, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 18 | 2020 |
| Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma A Gyurdieva, S Zajic, YF Chang, EA Houseman, S Zhong, J Kim, ... Nature communications 13 (1), 5296, 2022 | 17 | 2022 |
| Human herpesvirus 6B immediate‐early I protein contains functional HLA‐A*02, HLA‐A*03, and HLA‐B*07 class I restricted CD8+ T‐cell epitopes M Iampietro, G Morissette, A Gravel, I Dubuc, M Rousseau, A Hasan, ... European journal of immunology 44 (12), 3573-3584, 2014 | 15 | 2014 |
| Ocular outcomes after treatment of cytomegalovirus retinitis using adoptive immunotherapy with cytomegalovirus-specific cytotoxic T lymphocytes MP Gupta, LR Koenig, E Doubrovina, A Hasan, PB Dahi, RJ O’Reilly, ... Ophthalmology Retina 5 (9), 838-849, 2021 | 12 | 2021 |
| Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant SE Prockop, A Hasan, E Doubrovina, PB Dahi, I Rodriguez-Sanchez, ... The Journal of Clinical Investigation 133 (10), 2023 | 11 | 2023 |
